不稳定心绞痛患者血管性假血友病因子及同型半胱氨酸水平的改变被引量：3

Changes of von Willebrand factor and homocysteine in patients with unstable angina pectoris

导出

摘要目的　观察不稳定心绞痛患者血管性假血友病因子 (vWF)及同型半胱氨酸 (Hcy)水平的变化。方法　不稳定心绞痛患者 4 4例及冠状动脉造影正常患者 17例在入院次晨空腹采血 ,而健康体检人群 2 0例在当日空腹采血 ,测定vWF及Hcy水平。结果　不稳定心绞痛患者vWF及Hcy水平 [vWF(194 .36± 32 .2 3) % ,Hcy(12 .89± 5 .18) μmol L]较冠状动脉造影正常患者 [vWF(16 9.0 0± 2 0 .6 9) % ,Hcy(7.4 0± 5 .18) μmol L]和健康体检人群 [vWF(15 3.0 0±2 4 .73) % ,Hcy(4 .98± 1.5 9) μmol L]均明显升高。 Objective To observe the levels of von Willebrand factor(vWF) and homocysteine(Hcy) in patients with unstable angina pectoris(UAP).Methods Plasma levels of vWF and serum levels of homocysteine were measured by ELISA from 44 patients with UAP, 17 patients whose results of CAG were normal, and 20 healthy individuals.Results The levels of circulating vWF and Hcy in UAP [vWF(194.36±32.23)%, Hcy(12.89±5.18) μmol/L]were significantly higher than which in the individuals whose results of CAG were normal [vWF(169.00± 20.69)%, Hcy(7.40 ±5.18) μmol/L]and the healthy individuals. Conclusion Plasma vWF and Hcy may be possibly involved in the pathophysiology of UAP [vWF(153.00±24.73)%, Hcy(4.98±1.59) μmol/L].

作者黄琪胡申江孙坚

机构地区浙江大学医学院附属第一医院心内科

出处《医师进修杂志》北大核心 2004年第7期17-19,共3页 Journal of Postgraduates of Medicine

关键词不稳定心绞痛血管性假血友病因子同型半胱氨酸 unstable angina pectoris von Willebrand factor homocysteine

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献9

1SULLIVAN D R,MARWICK T H,FREEDMAN S B.A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with majory risk[J].Am Heart J,1990,119:1 262-1 267.
2FRYER R H,WILSON B D,GUBLER D B,et al. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells[J].Arterioscler Thromb,1993,13:1 327-1 333.
3FREYBURGER G,LABROUCHE S,SASSOIST G,et al.Mild hyperhomocysteinemia and hemostatic factors in patients with arterial vascular disease[J]. Thromb Haemost,1997,73:466-471.
4SCHUMACHER A,SELJEFLOT I,SOMMERVOLL L,et al.Increased levels of endothelial haemostatic markers in patients with coronary heart disease[J].Thromb Res,2002,105:25-31.
5LIP G Y,BLANN A.von Willebrand factor: a marker of endothelial dysfunction in vascular disorders[J].Cardiovasc Res,1997,34:255-265.
6BRUNNER M,FABER T S,GREVE B,et al. Usefulness of carvedilol in unstable angina pectoris[J].Am J Cardiol,2000,85:173-178.
7WHINCUP P H,REFSUM H,PERRY I J,et al. Serum total homocysteine and coronary heart disease: prospectice study in middle aged men[J]. Heart,1999,82:448-454.
8OMLAND T,SAMUELSSON A,HARTFORD M,et al. Seum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes[J]. Arch Intern Med,2000,160:1 834-1 840.
9AL-OBAIDI M K,PHILIPPOU H,STUBBS P J,et al. Relationships between homocysteine,factor Ⅶa,and thrombin generation in acute coronary syndromes[J]. Circulation,2000,101:372-377.